Resolor, INN-prucalopride
Prucalopride | CAS:179474-81-8 | 5-HT4A and 5-HT4B receptor agonist | High Purity | Manufacturer BioCrick
Prucalopride succinate (Resolor) | New Drug Approvals
Action mechanism of prokinetic agents in gastrointestinal tract. | Download Scientific Diagram
Prucalopride
Review of efficacy and safety of laxatives use in geriatrics. - Abstract - Europe PMC
Proposed mechanism of action of linaclotide. GC-C, guanylate cyclase... | Download Scientific Diagram
Prucalopride
Frontiers | Luminally Acting Agents for Constipation Treatment: A Review Based on Literatures and Patents | Pharmacology
New therapeutic perspectives in irritable bowel syndrome: Targeting low-grade inflammation, immuno-neuroendocrine axis, motility, secretion and beyond
Prucalopride
Prucalopride
Review article: linaclotide for the management of irritable bowel syndrome with constipation - Layer - 2014 - Alimentary Pharmacology & Therapeutics - Wiley Online Library
Prucalopride
Review of efficacy and safety of laxatives use in geriatrics. - Abstract - Europe PMC
Action mechanism of prokinetic agents in gastrointestinal tract. | Download Scientific Diagram
Chronic constipation and treatment options (Review)
An Open-Label, Head to Head Comparison Study between Prucalopride and Lactulose for Clozapine Induced Constipation in Patients w
Genotoxicity and carcinogenicity risk assessment of prucalopride, a selective 5-hydroxytryptamine 4 receptor agonist - ScienceDirect
Frontiers | Luminally Acting Agents for Constipation Treatment: A Review Based on Literatures and Patents | Pharmacology
Mechanism of prosecretory agents in the gastrointestinal tract. | Download Scientific Diagram
Prucalopride succinate (Resolor) | New Drug Approvals
Prucalopride
Prucalopride
